Geistlich Pharma North America, Inc. is a leading provider of regenerative dentistry products, offering innovative solutions for oral regenerative surgery. Their portfolio includes the groundbreaking GEM 21S, the first recombinant growth factor product for use in oral regenerative surgery, as well as the vallos line of allograft granules and fibers. With a focus on predictability and clinical outcomes, Geistlich Pharma North America provides resources and educational events to support dental professionals in achieving regenerative success.
With over 15 million patients benefiting from their products worldwide, Geistlich Pharma North America is a trusted name in the field of bone regeneration. Their range of products includes Geistlich Bio-Oss, the leading bone substitute for regenerative dentistry, Geistlich Bio-Gide, the leading collagen membrane for oral tissue regeneration, and Yxoss CBR, a cutting-edge bone substitute. Stay connected with Geistlich Pharma North America to stay up to date with their latest news and events.
Generated from the website